WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2020> 31> 4

Volume: 31 Issue: 4

1. Gynecologic oncology at the time of COVID-19 outbreak Page:e72—
2. FIGO staging in ovarian carcinoma and histological subtypes Page:e70—
3. Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists Page:e68—
4. Epithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery Page:e57—
5. Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database Page:e56—
6. Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014 Page:e52—
7. Stage III uterine serous carcinoma: modern trends in multimodality treatment Page:e53—
8. Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study Page:e51—
9. SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells Page:e46—
10. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG):disparity between serous carcinoma and clear cell carcinoma Page:e45—
11. The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma Page:e47—
12. The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy Page:e36—
13. Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer Page:e42—
14. Safety evaluation of abdominal trachelectomy in patients with cervical tumors ≥2 cm: a single-institution, retrospective analysis Page:e41—
15. Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma Page:e39—
16. Gynecologic oncology at the time of COVID-19 outbreak Page:e72—
17. FIGO staging in ovarian carcinoma and histological subtypes Page:e70—
18. Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists Page:e68—
19. Epithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery Page:e57—
20. Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database Page:e56—
21. Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014 Page:e52—
22. Stage III uterine serous carcinoma: modern trends in multimodality treatment Page:e53—
23. Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study Page:e51—
24. SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells Page:e46—
25. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG):disparity between serous carcinoma and clear cell carcinoma Page:e45—
26. The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma Page:e47—
27. The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy Page:e36—
28. Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer Page:e42—
29. Safety evaluation of abdominal trachelectomy in patients with cervical tumors ≥2 cm: a single-institution, retrospective analysis Page:e41—
30. Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma Page:e39—